Valesco Healthcare Gp LLC is categorized under Drugs, Proprietaries, and Sundries in New York City, NY and active since 2007.
Valesco Healthcare Gp LLC was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Linvsay Rosenwald at the company’s single location by writing to 787 Seventh Avenue Floor 48, New York City, New York NY 10019 or by phoning (985) 893-7313. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Valesco Healthcare Gp LLC |
Contact Person: | Linvsay Rosenwald |
Address: | 787 Seventh Avenue Floor 48, New York City, New York 10019 |
Phone Number: | (985) 893-7313 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Drugs, Proprietaries, and Sundries |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Valesco Healthcare Gp LLC was started in 2007 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Linvsay Rosenwald for inquiries that concern Valesco Healthcare Gp LLC by calling the company number (985) 893-7313, as your correspondence is most welcome. Additionally, the physical location of the single location of Valesco Healthcare Gp LLC can be found at the coordinates 40.762117,-73.982307 as well as the street address 787 Seventh Avenue Floor 48 in New York City, New York 10019.
For its online presence, you may visit Valesco Healthcare Gp LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.